TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: Bioventix lifts payout as revenue rises, but profit slips
Read moreIN BRIEF: Bioventix reports first-half fall in profit, raises dividend
Read more(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise
Read moreUK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix
Read more(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Read moreCORRECT: Bioventix Reports "Strong" Interims, Increases Dividend
Read moreBioventix Reports "Strong" Interim Performance, Increases Dividend
Read moreDIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares
Read more(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue for the year on Monday, to £9.3m.
Read more(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.
Read more